Literature DB >> 12147785

Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers.

Michael Freundlich1, Evelyn Alonzo, Ezequiel Bellorin-Font, Jose R Weisinger.   

Abstract

BACKGROUND: Patients with nephrolithiasis and idiopathic hypercalciuria (IH) may exhibit reduced bone mineral density (BMD). Most studies measuring BMD in IH patients employing dual-energy X-ray absorptiometry (DEXA) have been performed in adults, and no study has been conducted in North-American children. Optimal bone mineral accretion during childhood and adolescence is critical to the attainment of a healthy adult skeleton. Bone mineral accretion and eventual adult peak bone mass are largely dependent on genetic factors. Hypercalciuria is also frequently linked to genetic determinants. Therefore, we carried out a cross-sectional evaluation of bone mineral metabolism in children with IH, and in their asymptomatic premenopausal mothers.
METHODS: Quantitative BMD using DEXA was performed in 21 children with IH and in their asymptomatic mothers. Bone resorption was assessed by measuring the urinary concentrations of pyridinoline and deoxypiridinoline. Simultaneous calcium-modulating hormonal determinations, including serum intact immunoreactive parathyroid hormone and 1,25(OH)(2)D(3), were performed. The expression of interleukin-1alpha (IL-1alpha) by peripheral blood mononuclear cells (PBMCs) was determined by polymerase chain reaction.
RESULTS: Reduced BMD values were observed in eight children (38%) and in seven mothers (33%). The children of osteopenic mothers exhibited significantly reduced BMD Z-score values of lumbar spine (P<0.05) when compared with children of mothers with normal BMD. Bone resorption markers were normal in most children with IH. Hypercalciuria was detected in five out of 20 (25%) asymptomatic mothers and it correlated (r=-0.81) to femoral BMD in mothers with osteopenia. The expression of IL-1alpha mRNA by PBMCs from IH children did not differ from controls.
CONCLUSIONS: Reduced BMD was detected in a large proportion of children with IH. Hypercalciuria and reduced BMD were uncovered in a substantial number of their otherwise healthy asymptomatic mothers. The diminished BMD in adults with IH may start early in life, could be influenced by genetic factors, and may represent a risk factor for osteoporosis later in life.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147785     DOI: 10.1093/ndt/17.8.1396

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  17 in total

1.  Bone mineral density and bone turnover in patients with Bartter syndrome.

Authors:  Juan Rodríguez-Soriano; Alfredo Vallo; Mireia Aguirre
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

Review 2.  Bone disease and hypercalciuria in children.

Authors:  Joseph E Zerwekh
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

Review 3.  Bone disease in pediatric idiopathic hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2012-04-06

4.  Effect of thiazides on bone mineral density in children with idiopathic hypercalciuria.

Authors:  Víctor García-Nieto; Margarita Monge-Zamorano; Montserrat González-García; María Isabel Luis-Yanes
Journal:  Pediatr Nephrol       Date:  2011-08-28       Impact factor: 3.714

5.  Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria.

Authors:  Augusto C S Santos; Eleonora M Lima; Maria Goretti M G Penido; Katia D Silveira; Mauro M Teixeira; Eduardo A Oliveira; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2012-01-07       Impact factor: 3.714

6.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

7.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

8.  Low bone density in children with hypercalciuria and/or nephrolithiasis.

Authors:  Andrew L Schwaderer; Robert Cronin; John D Mahan; Carlton M Bates
Journal:  Pediatr Nephrol       Date:  2008-08-12       Impact factor: 3.714

9.  Bisphosphonates in children with hypercalciuria and reduced bone mineral density.

Authors:  Michael Freundlich; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2008-08-13       Impact factor: 3.714

Review 10.  Pathophysiology of hypercalciuria in children.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2007-04-27       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.